Genelux Corporation
GNLX • NASDAQ
Genelux Corporation is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Thomas D. Zindrick, with a market cap of $105.1M.
CEOThomas D. Zindrick
Market Cap$105.1M
Biotechnology
Healthcare
Employees23.0
Websitegenelux.com
Country
United States of America
Next Earnings
Upcoming earnings announcement for Genelux Corporation
Date
Tuesday, May 5, 2026 (in 3 months)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.21
Earnings History
Past 10 earnings reports for Genelux Corporation
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Nov 5, 2025 | Q3 2025 | -$0.21Est: -$0.22 | +4.5% | - | — |  10-Q |
| Aug 7, 2025 | Q2 2025 | -$0.20Est: -$0.22 | +9.1% | - | — | 10-Q |
| May 6, 2025 | Q1 2025 | -$0.21Est: -$0.26 | +19.2% | - | — | 10-Q |
| Mar 28, 2025 | Q4 2024 | -$0.25Est: -$0.19 | -31.6% | - | — | 10-K/A |
| Nov 14, 2024 | Q3 2024 | -$0.19Est: -$0.18 | -5.6% | - | — | 10-Q |
| Aug 14, 2024 | Q2 2024 | -$0.22Est: -$0.24 | +8.3% | - | — | 10-Q |
| May 9, 2024 | Q1 2024 | -$0.29Est: -$0.23 | -26.1% | $8.0K | — | 10-Q |
| Apr 1, 2024 | Q4 2023 | -$0.25Est: -$0.19 | -31.6% | - | — | 10-K |
| Nov 14, 2023 | Q3 2023 | -$0.20Est: -$0.18 | -11.1% | - | — | — |
| Aug 14, 2023 | Q2 2023 | -$0.23Est: -$0.15 | -53.3% | - | — | 10-Q |